国家自然科学基金（负责人）：
1. 2013年国家自然科学基金青年科学基金项目题目：免疫蛋白质组学筛选卵巢癌肿瘤抗原及其功能研究；批准号：81302276；经费：23万。
2. 2017年国家自然科学基金面上项目题目：Annexin A1通过调控TGF-β 受体内吞促进人卵巢癌细胞增殖的机制研究；批准号：81672577；经费：57万。
主要论著：
1. Zhang S, Yu M, Guo Q, et al. Annexin A2 binds to endosomes and negatively regulates TLR4-triggered inflammatory responses via the TRAM-TRIF pathway.Sci Rep. 2015;5:15859.
2. Zhang S, Wu M, Gao H. Editorial: NFAT signaling: no FAT as new weapon to fight shock. J Leukoc Biol. 2015;97(6):997-9.
3. Zhang S, Yu M, Deng H, et al. Polyclonal rabbit anti-human ovarian cancer globulins inhibit tumor growth through apoptosis involving the caspase signaling. Sci Rep. 2014;4:4984.
4. Zhang S, Yu M, Wei Y. Do anti-angiogenic cancer therapies increase risk of significant weight loss? Expert Opin Drug Saf. 2014;13(4):473-82.
5. Zhang S, Cao ZX, Tian HW, et al. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo. Clin Cancer Res. 2011;17:4439-50.
